Anxiety after an abnormal screening mammogram is a serious problem

Breast

Volumn 21, Issue 1, 2012, Pages 83-88

  Keyzer Dekker, Claudia M G ^a   De Vries, Jolanda ^b,c   van Esch, Lotje ^b   Ernst, Miranda F ^d   Nieuwenhuijzen, Grard A P ^e   Roukema, Jan A ^b,c   van der Steeg, Alida F W ^b,c  

^a Location Alkmaar   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c CPRLab   (Netherlands)

^d JEROEN BOSCH HOSPITAL   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

Author keywords

Breast cancer screening; False positive; Mammogram; Personality; Quality of life

Indexed keywords

ACCURACY; ADULT; ANXIETY; ARTICLE; BREAST CANCER; CANCER SCREENING; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL INFORMATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NETHERLANDS; NEUROTICISM EXTRAVERSION OPENNESS FIVE FACTOR INVENTORY; PERSONALITY; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSOCIAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; STATE TRAIT ANXIETY INVENTORY; WORLD HEALTH ORGANIZATION QUALITY OF LIFE ASSESSMENT INSTRUMENT BREF;

EID: 84856343440     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.08.137     Document Type: Article

References (40)

1. Gøtzsche P.C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011, 1. CD001877.
2. Fracheboud J., de Koning H.J., Beemsterboer P.M., Boer R., Hendriks J.H., Verbeek A.L., et al. Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. Int J Cancer 1998, 75:694-698. National Evaluation Team for Breast Cancer Screening.
3. Duijm L.E., Groenewoud J.H., Roumen R.M., de Koning H.J., Plaisier M.L., Fracheboud J. Adecade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer. Breast Cancer Res Treat 2007, 106:113-119. Epub 2007 Jan 12.
4. National Institute for Public Health and the Environment. The Netherlands. Available: [accessed 25.08.11.]. http://www.rivm.nl.
5. Elmore J.G., Barton M.B., Moceri V.M., Polk S., Arena P.J., Fletcher S.W. Ten-year risk of false positive screening mammograms and clinical breast examinations. NEngl J Med 1998, 338:1089-1096.
6. Brett J., Bankhead C., Henderson B., Watson E., Austoker J. The psychological impact of mammographic screening. A systematic review. Psychooncology 2005, 14:917-938.
7. Brewer N.T., Salz T., Lillie S.E. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007, 146:502-510.
8. Aro A.R., Pilvikki Absetz S., van Elderen T.M., van der Ploeg E., van der Kamp L.J. False-positive findings in mammography screening induces short-term distress - breast cancer-specific concern prevails longer. Eur J Cancer 2000, 36:1089-1097.
9. Salz T., Richman A.R., Brewer N.T. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology 2010, 19:1026-1034.
10. Woodward V., Webb C. Women's anxieties surrounding breast disorders: a systematic review of the literature. JAdv Nurs 2001, 33:29-41.
11. Montgomery M., McCrone S.H. Psychological distress associated with the diagnostic phase for suspected breast cancer: systematic review. JAdv Nurs 2010, 66:2372-2390.
12. van der Steeg A.F.W., Keyzer-Dekker C.M.G., De Vries J., Roukema J.A. Effect of abnormal screening mammogram on quality of life. Br J Surg 2011, 98:537-542.
13. Meechan G.T., Collins J.P., Moss-Morris R.E., Petrie K.J. Who is not reassured following benign diagnosis of breast symptoms?. Psychooncology 2005, 14:239-246.
14. Witek-Janusek L., Gabram S., Mathews H.L. Psychologic stress, reduced NK cell acitivity, and cytokine regulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology 2007, 32:22-35.
15. Brett J., Austoker J., Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. JPublic Health Med 1998, 20:396-403.
16. Hafslund B., Nortvedt M.W. Mammography screening from the perspective of quality of life: a review of the literature. Scand J Caring Sci 2009 Jan 7, [Epub ahead of print].
17. Brett J., Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. JPublic Health Med 2001, 23:292-300.
18. Lampic C., Thurfjell E., Sjödén P.O. The influence of a false-positive mammogram on a woman's subsequent behaviour for detecting breast cancer. Eur J Cancer 2003, 39:1730-1737.
19. Hoekstra H.A., Ormel J., De Fruyt F. Handleiding bij de NEO Persoonlijkheids vragenlijsten NEO-PI-R, NEO-FFI 1996, [manual for the NEO Personality Inventories NEO-PI-R and NEO-FFI], Swets & Zeitlinger B.V, Lisse: the Netherlands.
20. Costa P.T., McCrae R.R. NEO-PI-R: professional manual 1992, Psychological Assessment Resources, Odessa, FL.
21. Spielberger C.D., Gorsuch R.L., Lushene R.E. The state-trait anxiety inventory manual 1970, Consulting Psychologists Press, Palo Alto, CA.
22. Van der Ploeg H.M., Defares P.B., Spielberger C.D.Z.B.V. ADutch-language adaptation of the Spielberger state-trait anxiety inventory 1980, Swets & Zeitlinger, Lisse: The Netherlands.
23. Marteau T.M., Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992, 31:301-306.
24. Van der Bij A.K., De Weerd S., Cikot R.J., Steegers E.A., Braspenning J.C. Validation of the dutch short form of the state scale of the Spielberger State-Trait Anxiety Inventory: considerations for usage in screening outcomes. Community Genet 2003, 6:84-87.
25. Bogaarts M.P., Den Oudsten B.L., Roukema J.A., Van Riel J.M., Beerepoot L.V., De Vries J. Development of the Psychosocial Distress Questionnaire-Breast Cancer (PDQ-BC): a breast cancer-specific screening instrument for psychosocial problems. Support Care Cancer 2010, 4. [Epub ahead of print].
26. Schroevers M.J., Sanderman R., van Sonderen E., Ranchor A.V. The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: depressed and Positive Affect in cancer patients and healthy reference subjects. Qual Life Res 2000, 9:1015-1029.
27. Hann D., Winter K., Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). JPsychosom Res 1999, 46:437-443.
28. The World Health Organization quality of life Assesment (WHOQOL): development and general psychometric properties 1998, vol. 46. WHOQOL group, Soc Sci Med, pp. 1569-1585.
29. De Vries J., Van Heck G.L. De Nederlandse versie van de WHOQOL-100 1995, (The Dutch version of the WOQOL-100), Tilburg University, Tilburg, The Netherlands.
30. Van Esch L., Den Oudsten B.L., De Vries J. The World health Organization quality of life instrument - Short form (WHOQOL-BREF) in women with breast problems. Int J Clin Health Psychol 2011, 11:5-22.
31. Smith-Bindman R., Chu P.W., Miglioretti D.L., Sickles E.A., Blanks R., Ballard-Barbash R., et al. Comparison of screening mammography in the United States and the United kingdom. JAm Med Assoc 2003, 290:2129-2137.
32. Autier P., Boniol M., Gavin A., Vatten L.J. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011, 343:d4411.
33. McPherson K. Screening for breast cancer-balancing the debate. BMJ 2010, 340:c3106.
34. Welch H.G. Screening mammography-a long run for a short slide?. NEngl J Med 2010, 363:1276-1278.
35. Bonneux L. Advantages and disadvantages of breast cancer screening: time for evidence-based information. Ned Tijdschr Geneeskd 2009, 153:A887.
36. Baines C.J. Are there downsides to mammography screening?. Breast J 2005, 11:S7-S10.
37. Thornton H., Edwards A., Baum M. Women need better information about routine mammography. BMJ 2003, 327:101-103.
38. Feig S.A. Adverse effects of screening mammography. Radiol Clin North Am 2004, 42:807-819.
39. Slaytor E.K., Ward J.E. How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets. BMJ 1998, 317:263-264.
40. Jorgenson K.J., Gotzsche P. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ 2004, 328:148-154.